DAPAZORG 5 MG COM REV CT BL AL/AL X 100
Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil
-
Registration number
1650700500057 -
GGREM
569926080018607 -
Barcode
7908101202541
What the source publishes
- Holder
- CAMBER FARMACEUTICA LTDA
- Active ingredients
- DAPAGLIFLOZINA
- Package
- 5 MG COM REV CT BL AL/AL X 100
- Supply regime
- Tarja Vermelha
- Product type
- Similar
- Therapeutic class
- A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "DAPAZORG 5 MG COM REV CT BL AL/AL X 100",
"holder": "CAMBER FARMACEUTICA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7908101202541"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "569926080018607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "24.633.934/0001-29",
"priceRegime": "Regulado",
"productName": "DAPAZORG",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "5 MG COM REV CT BL AL/AL X 100",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "153.97",
"icms-12": "174.97",
"icms-17": "185.51",
"icms-18": "187.77",
"icms-19": "190.09",
"icms-20": "192.46",
"icms-21": "194.90",
"icms-22": "197.40",
"icms-23": "199.96",
"icms-17.5": "186.63",
"icms-19.5": "191.27",
"icms-20.5": "193.67",
"icms-22.5": "198.67",
"icms-12-alc": "172.87",
"icms-17-alc": "183.28",
"icms-18-alc": "185.52",
"icms-19-alc": "187.81",
"icms-20-alc": "190.15",
"icms-21-alc": "192.56",
"icms-22-alc": "195.03",
"icms-23-alc": "197.56",
"withoutTaxes": "152.12",
"icms-17.5-alc": "184.39",
"icms-19.5-alc": "188.97",
"icms-20.5-alc": "191.35",
"icms-22.5-alc": "196.29"
},
"pisCofinsList": "Positiva",
"substanceText": "DAPAGLIFLOZINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "212.23",
"icms-12": "241.18",
"icms-17": "255.71",
"icms-18": "258.82",
"icms-19": "262.02",
"icms-20": "265.29",
"icms-21": "268.65",
"icms-22": "272.10",
"icms-23": "275.62",
"icms-17.5": "257.25",
"icms-19.5": "263.65",
"icms-20.5": "266.95",
"icms-22.5": "273.85",
"icms-12-alc": "238.98",
"icms-17-alc": "253.37",
"icms-18-alc": "256.47",
"icms-19-alc": "259.64",
"icms-20-alc": "262.87",
"icms-21-alc": "266.20",
"icms-22-alc": "269.62",
"icms-23-alc": "273.12",
"withoutTaxes": "210.30",
"icms-17.5-alc": "254.91",
"icms-19.5-alc": "261.24",
"icms-20.5-alc": "264.53",
"icms-22.5-alc": "271.36"
},
"invalidBarcodes": [],
"activeSubstances": [
"DAPAGLIFLOZINA"
],
"therapeuticClass": "A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1650700500057",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10P1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:569926080018607"